文献
J-GLOBAL ID:202002254405621187
整理番号:20A2468914
中国の神経膠腫患者における20mgおよび100mgテモゾロミドカプセル(TOZ309およびTemodal Overhaus)の生物学的同等性研究【JST・京大機械翻訳】
Bioequivalence study of 20-mg and 100-mg temozolomide capsules (TOZ309 and Temodal) in glioma patients in China
著者 (8件):
Hu Chaoying
(Department of Pharmacy Phase I Clinical Trial Center, National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital of Capital Medical University, Beijing, China)
,
Lin Qingtang
(Department of Neurosurgery, National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital of Capital Medical University, Beijing, China)
,
Liu Chuan
(Department of Geriatrics, National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital of Capital Medical University, Beijing, China)
,
Liu Jacqueline
(TOT Biopharm Ltd, Suzhou, China)
,
Chen Xiaobao
(TOT Biopharm Ltd, Suzhou, China)
,
Li Xinxia
(TOT Biopharm Ltd, Suzhou, China)
,
Zhao Guoguang
(Department of Neurosurgery, National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital of Capital Medical University, Beijing, China)
,
Zhang Lan
(Department of Pharmacy Phase I Clinical Trial Center, National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital of Capital Medical University, Beijing, China)
資料名:
Cancer Chemotherapy and Pharmacology
(Cancer Chemotherapy and Pharmacology)
巻:
86
号:
6
ページ:
793-801
発行年:
2020年
JST資料番号:
W4134A
ISSN:
1432-0843
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)